Evasc Neurovascular

Evasc Neurovascular Enterprises, founded in 2001 and based in Vancouver, Canada, is a medical device company specializing in innovative endovascular treatments for cerebral aneurysms, particularly wide-neck bifurcations. The company develops non-tubular nitinol devices that facilitate neck bridging, flow diversion, coil retention, and endothelial growth across aneurysm necks, aiming to treat about 95% of cerebral aneurysm cases with enhanced safety and outcomes compared to traditional methods.

Evasc's core technology includes the patented eCLIPs family of devices, designed for challenging wide-neck bifurcation aneurysms. Key products include the eCLIPs Bifurcation Aneurysm Remodeling System, the Electrolytic eCLIPs Bifurcation device, and the eCLIPs Bifurcation Flow Diverter. The company has achieved significant clinical milestones, treating over 120 patients across Canada and Europe, and has received key regulatory approvals, including Canada's Special Access Program and the CE Mark. Evasc is committed to advancing neurovascular care globally, with ongoing clinical trials to validate its products.